Back to All Events

From Remdesivir to Human Convalescent Plasma: Understanding COVID-19 Therapeutic Development

Sponsored by the American Society for Microbiology

Join ASM for the concluding event in its briefing series showcasing the latest science behind COVID-19 Diagnostics, Vaccines, and Therapeutics. ASM president Dr. Robin Patel, and ASM experts Dr. Arturo Casadevall and Dr. Mark Denison will discuss how scientists are leveraging decades of basic and clinical research to bring innovative and effective therapies to the market for COVID-19. The webinar will explore groundbreaking work into the use of human convalescent plasma, how we can apply knowledge from existing antivirals to the novel disease, and what is needed from Congress and the Administration to ensure safe and effective therapies can get to the patients who need them.

For more information, click here. To register, click here.

Questions? Contact Mary Lee Watts at mwatts@asmusa.org